Depo Medroxyprogesterone acetate

DRUG4 trials

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Emory University, Universitas Diponegoro, University of California, San Diego

Conditions

Chlamydia InfectionDMPADepot Medroxyprogesterone AcetateEndometriosis OvaryHIVLactationNeisseriaceae InfectionPostpartum Contraception

Phase 3

Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery

CompletedNCT06145438

Universitas DiponegoroEndometriosis Ovary

Start: 2023-09-04End: 2024-11-19Updated: 2024-12-11

Phase 4

Measuring Lactation Initiation After Early Postpartum Injectable Progestin (DMPA) Use Among Women in Dhanusha District of Nepal: A Pilot Study

CompletedNCT06816901

University of California, San DiegoDepot Medroxyprogesterone Acetate, DMPA, Lactation +1

Start: 2025-03-26End: 2025-07-31Updated: 2025-09-10

Unknown Phase

Hormonal Contraception and Risk of Chlamydia and Gonorrhea

TerminatedNCT00091728

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Chlamydia Infection, Neisseriaceae Infection

Start: 1997-09-30End: 2001-08-31Target: 1200Updated: 2005-11-07

Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi

CompletedNCT01191203

Emory UniversityHIV

Start: 2010-07-31End: 2011-12-31Updated: 2013-10-25